Work Area: Valuation

Latest content

The brokered patent market in 2021

Featured in Special Report 2022 Q1: Patent Dealmaking

ROI’s latest report on sales activity and reflections on 10 years of market tracking

02 March 2022

The life science royalty sales market

Featured in Special Report 2022 Q1: Patent Dealmaking

Some of the highest-value deals in intellectual property today are taking place in the burgeoning marketplace for revenue streams linked to pharmaceutical products

02 March 2022

US patent assignments in 2021

Featured in Special Report 2022 Q1: Patent Dealmaking

Six things we learned about the transactions marketplace in a year that featured notable patent deals both big and small

02 March 2022

The brokered patent market in 2021

Featured in Secondary Market Activity

02 March 2022

More is being done than ever before to monetise neglected pharma IP

Roivant’s most recent spinout shows that it is still on the hunt for deprioritised life sciences patents

22 February 2022

How platform technologies are reshaping life sciences IP value creation

Versatile biotechnologies are changing patterns of collaboration among healthcare innovators

10 February 2022

Buyer and seller can be pleased with the BlackBerry patent sale’s outcome

The Canadian company has secured another three years’ worth of income from an encumbered portfolio, while the buyers can take high-quality assets into new markets

03 February 2022

GSK lands one of the biggest patent settlements of all time

The billion-dollar-plus agreement shows the astronomical financial value that individual pharmaceutical patents can have

03 February 2022

Big tech dominates brand value rankings led by $355 billion Apple portfolio

Tech sector brand assets gained significant value over the past year, according to the latest Brand Finance Global 500

31 January 2022

CRISPR IP deals continue apace despite legal battles

Spate of recent transactions show the value of gene-editing patents beyond Cas9

28 January 2022

Unlock unlimited access to all IAM content